Study Complete
Sponsor ID
20210057

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Sponsor ID
20210057
Clinicaltrials.gov ID
NCT05378529
EUCTIS ID
N/A
EudraCT ID
N/A

Study Details

The purpose of this study is to characterize the distribution of lipoprotein(a) (Lp(a)) levels among participants with a history of ASCVD as defined by their medical history and is 2-fold:

- Evaluate the distribution of Lp(a) value in the overall participants with documented history of ASCVD

- Evaluate the distribution of Lp(a) value in participants with documented history of ASCVD by demographics and regions

Additional Study Details

Phase
N/A
Product
Olpasiran
Type
Interventional
Masking
None (Open Label)
Enrollment
39480
Additional Study Details

Protocol Summary

Primary Outcome Measures

Number of participants with elevated Lp(a) with documented history of ASCVD

Timeframe: Up to approximately 2 weeks

Secondary Outcome Measures

Lp(a) Levels

Timeframe: Up to approximately 2 weeks

Lp(a) Levels stratified by demographics and region

Timeframe: Up to approximately 2 weeks

Study Documents

Plain Language Summary of Results
Available Language(s): English, Dutch, Finnish, Russian (Estonia), Swedish (Finland), French, Greek, Icelandic, German, Hungarian, Italian, Japanese, Lithuanian, Russian (Lithuania), Spanish (Mexico), Norwegian, Polish, Romanian, Portuguese (Native), Swedish, Korean, Spanish, Estonian, Danish, Czech, Chinese (Hong Kong), French (Canadian), English (Canada), Bulgarian, Portuguese (Brazil), French (Belgium), Dutch (Belgium), German (Austria), English (Australian), Spanish (Argentina), German (Switzerland), Spanish (United States), English (UK), Turkish, Chinese (Taiwan), French (Switzerland), Italian (Switzerland), Slovak

Locations

Location
Status
Contact Us
Location
Hygeia Hospital
Athens, Greece, 15123
Status
Completed
Location
Lillestol Research LLC
Fargo, ND, United States, 58104
Status
Completed
Location
America Clinical Trials
Tarzana, CA, United States, 91356
Status
Completed
Location
Piedmont Research Partners
Fort Mill, SC, United States, 29707
Status
Completed
Location
Midwest Heart and Vascular Specialists
Overland Park, KS, United States, 66211
Status
Completed
Location
CEDIC Centro de Investigacion Clinica
CABA, Buenos Aires, Argentina, 1060
Status
Completed
Showing {first} - {last} of {total} Results